APA

Lichtenstein K. A., Armon C., Nagabhushanam V., Efaw B. J., Frazer-Abel A., Hiserote M. E. & Alam R. (20130426). A pilot study to assess inflammatory biomarker changes when raltegravir is added to a virologically suppressive HAART regimen in HIV-1-infected patients with limited immunological responses. : Antiviral therapy.

Chicago

Lichtenstein Kenneth A, Armon Carl, Nagabhushanam Vijaya, Efaw Benjamin J, Frazer-Abel Ashley, Hiserote Melissa E and Alam Rafeul. 20130426. A pilot study to assess inflammatory biomarker changes when raltegravir is added to a virologically suppressive HAART regimen in HIV-1-infected patients with limited immunological responses. : Antiviral therapy.

Harvard

Lichtenstein K. A., Armon C., Nagabhushanam V., Efaw B. J., Frazer-Abel A., Hiserote M. E. and Alam R. (20130426). A pilot study to assess inflammatory biomarker changes when raltegravir is added to a virologically suppressive HAART regimen in HIV-1-infected patients with limited immunological responses. : Antiviral therapy.

MLA

Lichtenstein Kenneth A, Armon Carl, Nagabhushanam Vijaya, Efaw Benjamin J, Frazer-Abel Ashley, Hiserote Melissa E and Alam Rafeul. A pilot study to assess inflammatory biomarker changes when raltegravir is added to a virologically suppressive HAART regimen in HIV-1-infected patients with limited immunological responses. : Antiviral therapy. 20130426.